Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. 2022

Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.

Understanding the complex and specific roles played by non-coding RNAs (ncRNAs), which comprise the bulk of the genome, is important for understanding virtually every hallmark of cancer. This large group of molecules plays pivotal roles in key regulatory mechanisms in various cellular processes. Regulatory mechanisms, mediated by long non-coding RNA (lncRNA) and RNA-binding protein (RBP) interactions, are well documented in several types of cancer. Their effects are enabled through networks affecting lncRNA and RBP stability, RNA metabolism including N6-methyladenosine (m6A) and alternative splicing, subcellular localization, and numerous other mechanisms involved in cancer. In this review, we discuss the reciprocal interplay between lncRNAs and RBPs and their involvement in epigenetic regulation via histone modifications, as well as their key role in resistance to cancer therapy. Other aspects of RBPs including their structural domains, provide a deeper knowledge on how lncRNAs and RBPs interact and exert their biological functions. In addition, current state-of-the-art knowledge, facilitated by machine and deep learning approaches, unravels such interactions in better details to further enhance our understanding of the field, and the potential to harness RNA-based therapeutics as an alternative treatment modality for cancer are discussed.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069550 Machine Learning A type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data. Transfer Learning,Learning, Machine,Learning, Transfer
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D062085 RNA, Long Noncoding A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin. LincRNA,RNA, Long Untranslated,LINC RNA,LincRNAs,Long Intergenic Non-Protein Coding RNA,Long Non-Coding RNA,Long Non-Protein-Coding RNA,Long Noncoding RNA,Long ncRNA,Long ncRNAs,RNA, Long Non-Translated,lncRNA,Long Intergenic Non Protein Coding RNA,Long Non Coding RNA,Long Non Protein Coding RNA,Long Non-Translated RNA,Long Untranslated RNA,Non-Coding RNA, Long,Non-Protein-Coding RNA, Long,Non-Translated RNA, Long,Noncoding RNA, Long,RNA, Long Non Translated,RNA, Long Non-Coding,RNA, Long Non-Protein-Coding,Untranslated RNA, Long,ncRNA, Long,ncRNAs, Long

Related Publications

Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
January 2017, Frontiers in molecular biosciences,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
December 2021, Oncology reports,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
December 2008, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
February 2013, International journal of molecular sciences,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
November 2022, Scientific reports,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
January 2020, Protein and peptide letters,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
May 2018, Journal of hematology & oncology,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
September 2020, Aging,
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
January 2017, Medicinal chemistry (Shariqah (United Arab Emirates)),
Hibah Shaath, and Radhakrishnan Vishnubalaji, and Ramesh Elango, and Ahmed Kardousha, and Zeyaul Islam, and Rizwan Qureshi, and Tanvir Alam, and Prasanna R Kolatkar, and Nehad M Alajez
April 2019, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
Copied contents to your clipboard!